David Becker obtained his BSc in Biology in 1985 and his PhD in 1988 at University College London. In 1994 he was awarded a Royal Society Research Fellowship and in 2008 was made full Professor at UCL. In 2013 he moved to Singapore to join the newly formed Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore. For his translational research he has 30 worldwide patents pending and granted. In 2006 he was a founding scientist of CoDaTherapeutics Inc, (now Ocunexus) to develop Nexagon, a drug which promotes wound healing in skin and the cornea.
